But as each winter arrives, I understand more and more why my mum would drag me along on her daily walks when I was little.

An independent safety board has endorsed the continuation of BioXcel Therapeutics, Inc.'s (NASDAQ: BTAI) pivotal Phase 3 SERENITY At-Home trial evaluating BXCL501 for agitation tied to bipolar ...